|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
|---|---|
| Collaborators: |
National Institute of Allergy and Infectious Diseases (NIAID) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) National Institute of Environmental Health Sciences (NIEHS) Juvenile Diabetes Research Foundation Centers for Disease Control and Prevention |
| Information provided by: | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
| ClinicalTrials.gov Identifier: | NCT00279318 |
Purpose
The long-term goal of the TEDDY study is the identification of infectious agents, dietary factors, or other environmental agents, including psychosocial factors which trigger T1DM in genetically susceptible individuals or which protect against the disease. Identification of such factors will lead to a better understanding of disease pathogenesis and result in new strategies to prevent, delay or reverse T1DM.
| Condition |
|---|
|
Type 1 Diabetes Mellitus |
| Study Type: | Observational |
| Study Design: | Time Perspective: Prospective |
| Official Title: | Consortium for Identification of Environmental Triggers of Type 1 Diabetes |
Serum, plasma, PBMCs, stool, saliva, nasal swabs, nail clippings, water
| Enrollment: | 8668 |
| Study Start Date: | September 2004 |
| Estimated Study Completion Date: | September 2025 |
Epidemiologic patterns suggest that viruses, nutrition, toxic agents or socioeconomic psychosocial factors may contribute to the etiology alone or in combination. Elucidation is confounded by the long interval between exposure and onset of clinical disease, as well as the interaction of multiple genes and/or insults, which appear to interact in a complex manner. Numerous studies have investigated environmental influences but have yielded conflicting results. This may be in part due to the failure to account for genetic susceptibility, begin observation at early ages or in utero, and/or monitor subjects long term and frequently.
Hypotheses:
Initiation of persistent beta-cell autoimmunity and progression from beta-cell autoimmunity to diabetes is increased with:
Eligibility| Ages Eligible for Study: | up to 4 Months |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Childen up to 4 months of age with specified HLA are enrolled and followed longitudnally until 15 years of age
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| United States, Colorado | |
| University of Colorado Health Sciences Center | |
| Denver, Colorado, United States, 80262 | |
| United States, Florida | |
| Medical College of Georgia | |
| Gainesville, Florida, United States, 32608 | |
| United States, Georgia | |
| Medical College of Georgia | |
| Atlanta, Georgia, United States, 30342 | |
| Medical College of Georgia | |
| Augusta, Georgia, United States, 30912 | |
| United States, Pennsylvania | |
| Children's Hospital of Pittsburgh of UPMC (this site is only screening babies whose mother, father or full sibiling have type 1 diabetes) | |
| Pittsburgh, Pennsylvania, United States, 15213 | |
| United States, Washington | |
| Pacific Northwest Diabetes Research Institute | |
| Seattle, Washington, United States, 98122 | |
| Finland | |
| Turku University Central Hospital | |
| Turku, Finland, 20520 | |
| Germany | |
| Diabetes Research Institute | |
| Munich, Germany, 80804 | |
| Sweden | |
| University of Lund | |
| Malmo, Sweden, 20502 | |
| Principal Investigator: | Jeffrey P. Krischer, PhD | University of South Florida |
| Principal Investigator: | Marian J. Rewers, MD, PhD | University of Colorado Health Science Center |
| Principal Investigator: | William A. Hagopian, MD, PhD | Pacific Northwest Research Institute |
| Principal Investigator: | Ake Lernmark, MD, PhD | University of Washington & University of Lund |
| Principal Investigator: | Olli G. Simell, MD, PhD | University of Turku |
| Principal Investigator: | Jin-Xiong She, PhD | Georgia Health Sciences University |
| Principal Investigator: | Anette G. Ziegler, MD | University of Miami |
| Principal Investigator: | Beena Akolkar, PhD | National Institutes of Diabetes and Digestive Kidney Diseases |
More Information
| Responsible Party: | Dr. Jeffrey Krischer, University of South Florida |
| ClinicalTrials.gov Identifier: | NCT00279318 History of Changes |
| Other Study ID Numbers: | DK63790, 5U01DK063790-04 |
| Study First Received: | January 17, 2006 |
| Last Updated: | February 1, 2011 |
| Health Authority: | United States: Federal Government; United States: Institutional Review Board |
|
Environment Exposures Diet Toxins Psychosocial |
Infectious Agents Bacterial Viral Immunizations Autoantibody |
|
Diabetes Mellitus Diabetes Mellitus, Type 1 Glucose Metabolism Disorders Metabolic Diseases |
Endocrine System Diseases Autoimmune Diseases Immune System Diseases |